Search Results
Overview
| Uniprot ID | P11387 |
|---|---|
| Protein Name | DNA topoisomerase 1 |
| Gene Name | TOP1 |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position | Flanking peptide |
|---|---|
| 101 | VRASGDAKIKKEKEN |
| 137 | KEDIKPLKRPRDEDD |
| 150 | DDADYKPKKIKTEDT |
| 151 | DADYKPKKIKTEDTK |
| 164 | TKKEKKRKLEEEEDG |
| 172 | LEEEEDGKLKKPKNK |
| 184 | KNKDKDKKVPEPDNK |
| 202 | PKKEEEQKWKWWEEE |
| 299 | NIITNLSKCDFTQMS |
| 540 | DSIRYYNKVPVEKRV |
| 642 | APPKTFEKSMMNLQT |
Function
Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(3'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 5'-OH DNA strand. The free DNA strand then rotates around the intact phosphodiester bond on the opposing strand, thus removing DNA supercoils. Finally, in the religation step, the DNA 5'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Involved in the circadian transcription of the core circadian clock component BMAL1 by altering the chromatin structure around the ROR response elements (ROREs) on the BMAL1 promoter
Protein Sequence
Gene Ontology
| Classification | GO ID | Description |
|---|---|---|
| Cellular Component | GO:0005694 | chromosome |
| Cellular Component | GO:0001651 | dense fibrillar component |
| Cellular Component | GO:0001650 | fibrillar center |
| Cellular Component | GO:0005730 | nucleolus |
| Cellular Component | GO:0005654 | nucleoplasm |
| Cellular Component | GO:0005634 | nucleus |
| Cellular Component | GO:0000932 | P-body |
| Cellular Component | GO:0043204 | perikaryon |
| Cellular Component | GO:0032993 | protein-DNA complex |
| Molecular Function | GO:0005524 | ATP binding |
| Molecular Function | GO:0003682 | chromatin binding |
| Molecular Function | GO:0031490 | chromatin DNA binding |
| Molecular Function | GO:0003677 | DNA binding |
| Molecular Function | GO:0008301 | DNA binding, bending |
| Molecular Function | GO:0003917 | DNA topoisomerase type I (single strand cut, ATP-independent) activity |
| Molecular Function | GO:0003690 | double-stranded DNA binding |
| Molecular Function | GO:0140693 | molecular condensate scaffold activity |
| Molecular Function | GO:0019904 | protein domain specific binding |
| Molecular Function | GO:0004674 | protein serine/threonine kinase activity |
| Molecular Function | GO:0044877 | protein-containing complex binding |
| Molecular Function | GO:0003723 | RNA binding |
| Molecular Function | GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| Molecular Function | GO:0003697 | single-stranded DNA binding |
| Molecular Function | GO:0097100 | supercoiled DNA binding |
| Biological Process | GO:0031100 | animal organ regeneration |
| Biological Process | GO:0071373 | cellular response to luteinizing hormone stimulus |
| Biological Process | GO:0006338 | chromatin remodeling |
| Biological Process | GO:0007059 | chromosome segregation |
| Biological Process | GO:0032922 | circadian regulation of gene expression |
| Biological Process | GO:0007623 | circadian rhythm |
| Biological Process | GO:0006260 | DNA replication |
| Biological Process | GO:0006265 | DNA topological change |
| Biological Process | GO:0012501 | programmed cell death |
| Biological Process | GO:0051591 | response to cAMP |
| Biological Process | GO:0010332 | response to gamma radiation |
| Biological Process | GO:0009266 | response to temperature stimulus |
| Biological Process | GO:0009410 | response to xenobiotic stimulus |
| Biological Process | GO:0009303 | rRNA transcription |
Reference
[1] Yang D, Yin J, Shan L, Yi X, Zhang W et al.. Identification of lysine-lactylated substrates in gastric cancer cells.. iScience 25(7):104630. 2022 Jul 15. PMID: 35800753.
[2] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.
[3] Hong H, Chen X, Wang H, Gu X, Yuan Y et al.. Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma.. Proteomics 23(9):e2200432. 2023 May. PMID: 36625413.
[4] He C, Zhang J, Bai X, Lu C, Zhang K. Lysine lactylation-based insight to understanding the characterization of cervical cancer.. Biochim Biophys Acta Mol Basis Dis 1870(7):167356. 2024 Oct. PMID: 39025375.
[5] Bao Q, Wan N, He Z, Cao J, Yuan W et al.. Subcellular Proteomic Mapping of Lysine Lactylation.. J Am Soc Mass Spectrom 35(12):3221-3232. 2024 Dec 4. PMID: 39569522.
[6] He J, Lai T, Zhou Z, Yang H, Lei Z et al.. Multiomics profiling reveals the involvement of protein lactylation in nonhomologous end joining pathway conferring radioresistance in lung adenocarcinoma cell.. Sci Rep 15(1):24651. 2025 Jul 9. PMID: 40634431.
[7] Wu Q, Li Z, Gong T, Zheng X, Zhou X et al.. Porphyromonas gingivalis infection induces lysine lactylation reprogramming in human umbilical vein endothelial cells.. Front Cell Infect Microbiol 16:1706727. 2026. PMID: 41696360.